These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 2353941
41. The effects on 4-aminoantifolates on 5-formyltetrahydrofolate metabolism in L1210 cells. A biochemical basis of the selectivity of leucovorin rescue. Matherly LH, Barlowe CK, Phillips VM, Goldman ID. J Biol Chem; 1987 Jan 15; 262(2):710-7. PubMed ID: 2948949 [Abstract] [Full Text] [Related]
42. Biochemical and cellular pharmacology of 1843U89, a novel benzoquinazoline inhibitor of thymidylate synthase. Duch DS, Banks S, Dev IK, Dickerson SH, Ferone R, Heath LS, Humphreys J, Knick V, Pendergast W, Singer S. Cancer Res; 1993 Feb 15; 53(4):810-8. PubMed ID: 8428362 [Abstract] [Full Text] [Related]
43. Photoaffinity analogues of methotrexate as folate antagonist binding probes. 2. Transport studies, photoaffinity labeling, and identification of the membrane carrier protein for methotrexate from murine L1210 cells. Price EM, Freisheim JH. Biochemistry; 1987 Jul 28; 26(15):4757-63. PubMed ID: 3663624 [Abstract] [Full Text] [Related]
44. Transport of folate compounds by leukemic cells. Evidence for a single influx carrier for methotrexate, 5-methyltetrahydrofolate, and folate in CCRF-CEM human lymphoblasts. Henderson GB, Tsuji JM, Kumar HP. Biochem Pharmacol; 1987 Sep 15; 36(18):3007-14. PubMed ID: 3477231 [Abstract] [Full Text] [Related]
45. Enhancement of folate analogue transport inward in L1210 cells during methotrexate therapy of leukemic mice: evidence of the nature of the effect, possible host mediation, and pharmacokinetic significance. Sirotnak FM, Poser RE, Barrueco JR. Cancer Res; 1987 Oct 15; 47(20):5334-9. PubMed ID: 3498533 [Abstract] [Full Text] [Related]
46. Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines. Jackman AL, Kelland LR, Kimbell R, Brown M, Gibson W, Aherne GW, Hardcastle A, Boyle FT. Br J Cancer; 1995 May 15; 71(5):914-24. PubMed ID: 7537518 [Abstract] [Full Text] [Related]
47. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity. Westerhof GR, Schornagel JH, Kathmann I, Jackman AL, Rosowsky A, Forsch RA, Hynes JB, Boyle FT, Peters GJ, Pinedo HM. Mol Pharmacol; 1995 Sep 15; 48(3):459-71. PubMed ID: 7565626 [Abstract] [Full Text] [Related]
48. Suramin sodium: pronounced effects on methotrexate transport and anti-folate activity in cultured tumor cells. Rideout DC, Bustamante A, Patel R, Henderson GB. Int J Cancer; 1995 Jun 09; 61(6):840-7. PubMed ID: 7790120 [Abstract] [Full Text] [Related]
49. Comparison of methotrexate polyglutamylation in L1210 leukemia cells when influx is mediated by the reduced folate carrier or the folate receptor. Lack of evidence for influx route-specific effects. Spinella MJ, Brigle KE, Freemantle SJ, Sierra EE, Goldman ID. Biochem Pharmacol; 1996 Sep 13; 52(5):703-12. PubMed ID: 8765468 [Abstract] [Full Text] [Related]
50. Role of the amino acid 45 residue in reduced folate carrier function and ion-dependent transport as characterized by site-directed mutagenesis. Zhao R, Gao F, Wang PJ, Goldman ID. Mol Pharmacol; 2000 Feb 13; 57(2):317-23. PubMed ID: 10648641 [Abstract] [Full Text] [Related]
51. The mechanism of folate transport in rabbit reticulocytes. Bobzien WF, Goldman ID. J Clin Invest; 1972 Jul 13; 51(7):1688-96. PubMed ID: 5032520 [Abstract] [Full Text] [Related]
52. Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate. Pinard MF, Jolivet J, Ratnam M, Kathmann I, Molthoff C, Westerhof R, Schornagel JH, Jansen G. Cancer Chemother Pharmacol; 1996 Jul 13; 38(3):281-8. PubMed ID: 8646804 [Abstract] [Full Text] [Related]
53. Role of membrane-associated folate binding protein in the cytotoxicity of antifolates in KB, IGROV1, and L1210A cells. Schultz RM, Andis SL, Shackelford KA, Gates SB, Ratnam M, Mendelsohn LG, Shih C, Grindey GB. Oncol Res; 1995 Jul 13; 7(2):97-102. PubMed ID: 7579732 [Abstract] [Full Text] [Related]
54. Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells. Kühnel JM, Chiao JH, Sirotnak FM. J Cell Physiol; 2000 Sep 13; 184(3):364-72. PubMed ID: 10911368 [Abstract] [Full Text] [Related]
56. Further studies on the pharmacologic effects of the 7-hydroxy catabolite of methotrexate in the L1210 murine leukemia cell. Seither RL, Rape TJ, Goldman ID. Biochem Pharmacol; 1989 Mar 01; 38(5):815-22. PubMed ID: 2467676 [Abstract] [Full Text] [Related]
57. Variant GPI structure in relation to membrane-associated functions of a murine folate receptor. Wang X, Jansen G, Fan J, Kohler WJ, Ross JF, Schornagel J, Ratnam M. Biochemistry; 1996 Dec 17; 35(50):16305-12. PubMed ID: 8973205 [Abstract] [Full Text] [Related]
58. Relationship of reduced folate changes to inhibition of DNA synthesis induced by methotrexate in L1210 cells in vivo. Priest DG, Bunni M, Sirotnak FM. Cancer Res; 1989 Aug 01; 49(15):4204-9. PubMed ID: 2743307 [Abstract] [Full Text] [Related]